DOI QR코드

DOI QR Code

The role of interleukin-7 in Porphyromonas gingivalis-stimulated vascular calcification

  • Hyun-Joo Park (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Mi-Kyoung Kim (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Yeon Kim (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Soo-Kyung Bae (Dental and Life Science Institute, School of Dentistry, Pusan National University) ;
  • Hyung Joon Kim (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Moon-Kyoung Bae (Department of Oral Physiology, School of Dentistry, Pusan National University)
  • Received : 2024.11.19
  • Accepted : 2024.11.29
  • Published : 2024.12.31

Abstract

Periodontal disease has been implicated in the progression of various systemic diseases, including chronic kidney disease (CKD). Recent evidence suggests that infection of Porphyromonas gingivalis, a major periodontal pathogen, may also contribute to vascular calcification in patients with CKD. In the present study, antibody array analysis of serum samples from CKD mice administered with oral P. gingivalis revealed significant alterations in protein expression profiles, with notable interleukin-7 (IL-7) upregulation. We demonstrated that P. gingivalis infection enhances the inorganic phosphate-induced calcification of vascular smooth muscle cells (VSMCs), a pathological process that is characteristically accelerated in CKD. Notably, IL-7 expression was significantly upregulated in the P. gingivalis-stimulated calcification of VSMCs. Moreover, IL-7 knockdown in VSMCs markedly attenuated the P. gingivalis-stimulated calcification of VSMCs and suppressed the expression of osteogenic markers, including alkaline phosphatase and Runt-related transcription factor 2. These findings suggest that IL-7 plays a crucial role in P. gingivalis-stimulated vascular calcification, potentially providing new therapeutic targets for preventing vascular calcification in CKD patients with periodontal infection.

Keywords

Acknowledgement

This work was supported by a 2-Year Research Grant of Pusan National University.

References

  1. Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 2019;65:16-36. doi: 10.1016/j.mam.2018.06.002
  2. Zoccali C, Vanholder R, Massy ZA, et al. The systemic nature of CKD. Nat Rev Nephrol 2017;13:344-58. doi: 10.1038/nrneph.2017.52
  3. Dube P, DeRiso A, Patel M, et al. Vascular calcification in chronic kidney disease: diversity in the vessel wall. Biomedicines 2021;9:404. doi: 10.3390/biomedicines9040404
  4. Quaglino D, Boraldi F, Lofaro FD. The biology of vascular calcification. Int Rev Cell Mol Biol 2020;354:261-353. doi: 10.1016/bs.ircmb.2020.02.007
  5. McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med 2014;126:54-64. doi: 10.3810/pgm.2014.03.2740
  6. Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res 2014;2014:476068. doi: 10.1155/2014/476068
  7. Iwasaki M, Taylor GW, Manz MC, et al. Serum antibody to Porphyromonas gingivalis in chronic kidney disease. J Dent Res 2012;91:828-33. doi: 10.1177/0022034512455063
  8. Li L, Zhang YL, Liu XY, et al. Periodontitis exacerbates and promotes the progression of chronic kidney disease through oral flora, cytokines, and oxidative stress. Front Microbiol 2021;12:656372. doi: 10.3389/fmicb.2021.656372
  9. Park HJ, Kim Y, Kim MK, et al. Infection of Porphyromonas gingivalis increases phosphate-induced calcification of vascular smooth muscle cells. Cells 2020;9:2694. doi: 10.3390/cells9122694
  10. Liu G, Deng J, Zhang Q, et al. Porphyromonas gingivalis lipopolysaccharide stimulation of vascular smooth muscle cells activates proliferation and calcification. J Periodontol 2016;87:828-36. doi: 10.1902/jop.2016.150602
  11. Yang WW, Guo B, Jia WY, Jia Y. Porphyromonas gingivalisderived outer membrane vesicles promote calcification of vascular smooth muscle cells through ERK1/2-RUNX2. FEBS Open Bio 2016;6:1310-9. doi: 10.1002/2211-5463.12151
  12. Park HJ, Kim Y, Kim MK, et al. Inhibition of gastrin-releasing peptide attenuates phosphate-induced vascular calcification. Cells 2020;9:737. doi: 10.3390/cells9030737
  13. Ding N, Lv Y, Su H, et al. Vascular calcification in CKD: new insights into its mechanisms. J Cell Physiol 2023;238:1160-82. doi: 10.1002/jcp.31021
  14. Salimi S, Ng N, Seliger SL, Parsa A. Periodontal disease, renal dysfunction and heightened leukocytosis. Nephron Clin Pract 2014;128:107-14. doi: 10.1159/000366445
  15. Wei W, Sun J, Ji Z, Hu J, Jiang Q. Gingipain and oncostatin M synergistically disrupt kidney tight junctions in periodontitisassociated acute kidney injury. J Periodontol 2024;95:867-79. doi: 10.1002/JPER.24-0007
  16. França LFC, Vasconcelos ACCG, da Silva FRP, et al. Periodontitis changes renal structures by oxidative stress and lipid peroxidation. J Clin Periodontol 2017;44:568-76. doi: 10.1111/jcpe.12729
  17. Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells 2023;12:1581. doi: 10.3390/cells12121581
  18. Niedzielska I, Chudek J, Kowol I, et al. The odontogenic-related microinflammation in patients with chronic kidney disease. Ren Fail 2014;36:883-8. doi: 10.3109/0886022X.2014.894764
  19. Kapellas K, Singh A, Bertotti M, Nascimento GG, Jamieson LM; Perio-CKD collaboration. Periodontal and chronic kidney disease association: a systematic review and meta-analysis. Nephrology (Carlton) 2019;24:202-12. doi: 10.1111/nep.13225
  20. Ismail G, Dumitriu HT, Dumitriu AS, Ismail FB. Periodontal disease: a covert source of inflammation in chronic kidney disease patients. Int J Nephrol 2013;2013:515796. doi: 10.1155/2013/515796
  21. Maheshwari S, Chahal GS, Grover V, et al. Impact of periodontal treatment on inflammatory oxidative stress in chronic kidney disease subjects: an interventional clinical trial. Am J Dent 2023;36:15-20.
  22. Chaudhry A, Kassim NK, Zainuddin SLA, et al. Potential effects of non-surgical periodontal therapy on periodontal parameters, inflammatory markers, and kidney function indicators in chronic kidney disease patients with chronic periodontitis. Biomedicines 2022;10:2752. doi: 10.3390/biomedicines10112752
  23. Wahid A, Chaudhry S, Ehsan A, Butt S, Ali Khan A. Bidirectional relationship between chronic kidney disease & periodontal disease. Pak J Med Sci 2013;29:211-5. doi: 10.12669/pjms.291.2926
  24. Sharma P, Fenton A, Dias IHK, et al. Oxidative stress links periodontal inflammation and renal function. J Clin Periodontol 2021;48:357-67. doi: 10.1111/jcpe.13414
  25. Jian CX, Fan QS, Hu YH, et al. IL-7 suppresses osteogenic differentiation of periodontal ligament stem cells through inactivation of mitogen-activated protein kinase pathway. Organogenesis 2016;12:183-93. doi: 10.1080/15476278.2016.1229726
  26. Chen X, Fang L, Song S, Guo TB, Liu A, Zhang JZ. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway. J Immunol 2009;183:6135-44. doi: 10.4049/jimmunol.0901576
  27. Romanova Y, Laikov A, Markelova M, et al. Proteomic analysis of human serum from patients with chronic kidney disease. Biomolecules 2020;10:257. doi: 10.3390/biom10020257
  28. Colucci S, Mori G, Brunetti G, et al. Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an in vitro model derived from human periodontitis patients. Int J Immunopathol Pharmacol 2005;18(3 Suppl):13-9.